Olympus (OCPNY) Stock Price, News & Analysis

Company Overview

Olympus Corporation (OTCMKTS:OCPNY) is a Tokyo‐based multinational company specializing in precision optics and reprographics products. The company operates through three primary business segments: Medical Systems, Scientific Solutions and Imaging. Each segment focuses on the design, development and distribution of specialized equipment for healthcare, research and consumer applications.

Founded in Tokyo in 1919, Olympus has evolved from a manufacturer of microscopes and camera lenses into a leading provider of minimally invasive surgical systems and endoscopic visualization technologies. The company’s Medical Systems division offers endoscopes, visualization platforms and surgical energy devices used in gastroenterology, pulmonology and other medical specialties. Its Scientific Solutions segment supplies high‐performance microscopes, industrial borescopes and metal detectors for research laboratories and quality control in manufacturing.

Olympus serves a global customer base across North America, Europe, Asia and other regions, operating through a network of subsidiaries, distributors and service centers. The Imaging business provides digital cameras and related accessories aimed at photography enthusiasts and professionals. With a focus on innovation and quality, Olympus continues to invest in R&D to advance its core technologies and address emerging needs in healthcare and scientific research.

Key Stats

• Today's Range: $18.00 to $18.00
• 50-Day Range: $18.00 to $18.00
• 52-Week Range: $16.80 to $74.99
• Volume: 400 shs
• Average Volume: 860,265 shs
• Market Capitalization: $23.15 billion
• P/E Ratio: 21.95
• Dividend Yield: 0.44%
• Price Target: N/A
• Consensus Rating: N/A

OCPNY Stock Analysis - Frequently Asked Questions

How have OCPNY shares performed this year?

Olympus' stock was trading at $18.00 on January 1st, 2025. Since then, OCPNY stock has increased by 0.0% and is now trading at $18.00.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) posted its earnings results on Thursday, August, 5th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.10 by $0.03. The firm had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%.

Does Olympus have any subsidiaries?

The following companies are subsidiaries of Olympus: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and others.

How do I buy shares of Olympus?

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/05/2021
• Today: 9/21/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Structural clay products
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OCPNY
• CIK: N/A
• Web: www.olympus-global.com
• Phone: (133) 340-2111
• Fax: 813-3340-2062
• Employees: 31,557
• Year Founded: 1919

Profitability

• EPS (Trailing Twelve Months): $0.82
• Trailing P/E Ratio: 21.95
• Forward P/E Ratio: 10.91
• P/E Growth: 1.07
• Net Income: $1.03 billion
• Net Margins: 13.80%
• Pretax Margin: N/A
• Return on Equity: 24.30%
• Return on Assets: 9.30%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 1.99
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $7.74 billion
• Price / Sales: 2.99
• Cash Flow: $1.22 per share
• Price / Cash Flow: 14.76
• Book Value: $3.50 per share
• Price / Book: 5.14

Miscellaneous

• Outstanding Shares: 1,285,890,000
• Free Float: N/A
• Market Cap: $23.15 billion
• Optionable: Not Optionable
• Beta: 0.70